| Literature DB >> 15187120 |
Tyler J Curiel1, Cindy Morris, Michael Brumlik, Samuel J Landry, Kristiaan Finstad, Anne Nelson, Virendra Joshi, Christopher Hawkins, Xavier Alarez, Andrew Lackner, Mansour Mohamadzadeh.
Abstract
Dendritic cells (DC) play a critical role in adaptive immunity by presenting Ag, thereby priming naive T cells. Specific DC-binding peptides were identified using a phage display peptide library. DC-peptides were fused to hepatitis C virus nonstructural protein 3 (NS3) while preserving DC targeting selectivity and Ag immunogenicity. The NS3-DC-peptide fusion protein was efficiently presented to CD4+ and CD8+ T cells derived from hepatitis C virus-positive blood cells, inducing their activation and proliferation. This immunogenic fusion protein was significantly more potent than NS3 control fusion protein or NS3 alone. In chimeric NOD-SCID mice transplanted with human cells, DC-targeted NS3 primed naive CD4+ and CD8+ T cells for potent NS3-specific proliferation and cytokine secretion. The capacity of peptides to specifically target immunogenic Ags to DC may establish a novel strategy for vaccine development.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15187120 DOI: 10.4049/jimmunol.172.12.7425
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422